Two cases of acute exacerbation of interstitial pneumonia treated with polymyxin B-immobilized fiber column hemoperfusion treatment

Internal Medicine

Volumn 46, Issue 17, 2007, Pages 1447-1454

  Noma, Satoshi ^a   Matsuyama, Wataru ^a   Matsuyama, Hideo ^a   Suetsugu, Takayuki ^a   Koreeda, Yoshimizu ^a   Mizuno, Keiko ^a   Higashimoto, Ikkou ^a   Kakihana, Yasuyuki ^a   Hashiguchi, Teruto ^b   Maruyama, Ikuro ^b   Osame, Mitsuhiro ^a   Arimura, Kimiyoshi ^a  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage fluid cells; CD18+ CD11c; High mobility group box 1 (HMGB 1)

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYTOKINE; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MYELOPEROXIDASE; NAFAMSTAT MESILATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; POLYMYXIN B; PREDNISOLONE; SIVELESTAT; TORAYMIXIN 20R; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADULT; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; AUTOPSY; BRONCHOPNEUMONIA; CASE REPORT; COUGHING; DEATH; DISEASE EXACERBATION; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HEMOPERFUSION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; HYPOCAPNIA; HYPOXIA; INTERSTITIAL PNEUMONIA; KIDNEY BIOPSY; LUNG FIBROSIS; LUNG LAVAGE; MALE; MICROSCOPIC POLYANGIITIS; NEUTROPHIL; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; FATALITY; INTERSTITIAL LUNG DISEASE; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FATAL OUTCOME; FEMALE; HEMOPERFUSION; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMYXIN B; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 34548765548     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0117     Document Type: Article

References (32)

1. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 103: 1808-1812, 1993.
2. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 128: 3310-3315, 2005.
3. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 22: 821-826, 2003.
4. Parambil JG, Myers JL, Ryu JH. Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 130: 553-558, 2006.
5. Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjögren syndrome. Chest 130: 1489-1495, 2006.
6. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 168: 79-83, 1997.
7. Rice AJ, Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol 119: 709-714, 2003.
8. Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 9: R653-R661, 2005.
9. Nakamura T, Kawagoe Y, Matsuda T, et al. Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purif 22: 256-260, 2004.
10. Seo Y, Abe S, Kurahara M, et al. Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 45: 1033-1038, 2006.
11. Tsushima K, Kubo K, Koizumi T, et al. Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 17: 97-102, 2002.
12. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165: 277-304, 2002.
13. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824, 1994.
14. Yamada S, Inoue K, Yakabe K, Imaizumi H, Maruyama I. High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibo1y that does not cross-react with HMGB2. Clin Chem 49: 1535-1537, 2003.
15. Rollins BJ. Chemokines. Blood 90: 909-928, 1997.
16. Suzuki H, Nemoto H, Nakamoto H, et al. Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher 6: 234-240, 2002.
17. Naka T, Shinozaki M, Akizawa T, Shima Y, Takaesu H, Nasu H. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock. Ther Apher Dial 10: 7-11, 2006.
18. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, Muller-Quernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 157: 762-768, 1998.
19. Hsieh SC, Yu HS, Cheng SH, et al. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 anti-bodies leading to activation-induced cell death of the neutrophils. Clin Rheumatol 26: 216-224, 2007.
20. Tam FW, Sanders JS, George A, et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 19: 2761-2768, 2004.
21. Matsuyama W, Watanabe M, Shirahama Y, et al. Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis. J Imummol 174: 6490-6498, 2005.
22. Sakamoto Y, Mashiko K, Matsumoto H, et al. Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case. ASAIO J 52: e37-e39, 2006.
23. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther 8 (Suppl 2): S3, 2006.
24. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
25. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 165: 2950-2954, 2000.
26. Ueno H, Matsuda T, Hashimoto S, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170: 1310-1316, 2004.
27. Berton G, Laudanna C, Sorio C, Rossi F. Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils. J Cell Biol 116: 1007-1017, 1992.
28. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
29. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500, 2001.
30. Maus UA, Waelsch K, Kuziel WA, et al. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Imummol 170: 3273-3278, 2003.
31. Smith KA. The interleukin 2 receptor. Annu Rev Cell Biol 5: 397-425, 1989.
32. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for EP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 184: 963-969, 1996.